AR045284A1 - USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT - Google Patents
USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENTInfo
- Publication number
- AR045284A1 AR045284A1 ARP040102976A ARP040102976A AR045284A1 AR 045284 A1 AR045284 A1 AR 045284A1 AR P040102976 A ARP040102976 A AR P040102976A AR P040102976 A ARP040102976 A AR P040102976A AR 045284 A1 AR045284 A1 AR 045284A1
- Authority
- AR
- Argentina
- Prior art keywords
- disorders
- disorder
- inhibitor compound
- anxiety
- inhibitor
- Prior art date
Links
Abstract
Uso de compuesto, que es un inhibidor de la recaptación de serotonina, y un compuesto, que es un inhibidor del transportador de Glicina tipo 1 (GlyT-1), para la preparación de una composición farmacéutica para el tratamiento de depresión, trastornos de ansiedad y otros trastornos afectivos. En particular se refiere al tratamiento de depresión, trastornos de ansiedad y otros trastornos afectivos, tales como trastorno de ansiedad generalizada, ansiedad de pánico, trastorno compulsivo obsesivo, trastorno de estrés agudo, trastorno de estrés post-traumático y trastorno de ansiedad social, trastornos de la alimentación tales como bulimia, anorexia y obesidad, fobias, distimia, síndrome premenstrual, trastornos cognoscitivos, trastornos de control del impulsivo, trastorno de hiperactividad de déficit de atención, abuso de drogas o cualquier otro trastorno que responda a inhibidores de la recaptación de serotonina. Composición farmacéutica que comprende un inhibidor de la recaptación de serotonina y un inhibidor de Gly-T-1.Use of compound, which is a serotonin reuptake inhibitor, and a compound, which is an inhibitor of glycine transporter type 1 (GlyT-1), for the preparation of a pharmaceutical composition for the treatment of depression, anxiety disorders and other affective disorders. In particular it refers to the treatment of depression, anxiety disorders and other affective disorders, such as generalized anxiety disorder, panic anxiety, obsessive compulsive disorder, acute stress disorder, post-traumatic stress disorder and social anxiety disorder, disorders of eating such as bulimia, anorexia and obesity, phobias, dysthymia, premenstrual syndrome, cognitive disorders, impulse control disorders, attention deficit hyperactivity disorder, drug abuse or any other disorder that responds to reuptake inhibitors of serotonin Pharmaceutical composition comprising a serotonin reuptake inhibitor and a Gly-T-1 inhibitor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301198 | 2003-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045284A1 true AR045284A1 (en) | 2005-10-19 |
Family
ID=58707234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102976A AR045284A1 (en) | 2003-08-21 | 2004-08-19 | USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR045284A1 (en) |
| CO (1) | CO5680458A2 (en) |
| EA (1) | EA200600453A1 (en) |
| IL (1) | IL173825A0 (en) |
| ZA (1) | ZA200601084B (en) |
-
2004
- 2004-08-18 EA EA200600453A patent/EA200600453A1/en unknown
- 2004-08-18 ZA ZA200601084A patent/ZA200601084B/en unknown
- 2004-08-19 AR ARP040102976A patent/AR045284A1/en not_active Application Discontinuation
-
2006
- 2006-02-17 CO CO06016118A patent/CO5680458A2/en not_active Application Discontinuation
- 2006-02-20 IL IL173825A patent/IL173825A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL173825A0 (en) | 2006-07-05 |
| CO5680458A2 (en) | 2006-09-29 |
| ZA200601084B (en) | 2007-04-25 |
| EA200600453A1 (en) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124111T1 (en) | GLUTAMATE REGULATORS IN THE TREATMENT OF MENTAL DISORDERS | |
| ME00039B (en) | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | |
| DE60200492D1 (en) | Combination of an inhibitor of serotonin reuptake and an atypical antipsychotic for the treatment of depression, obsessive compulsive disorder and psychosis | |
| UY29223A1 (en) | PHENOXYACETIC ACIDS REPLACED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | |
| UY29839A1 (en) | PHENOXYACETIC ACIDS REPLACED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESSES FOR THEIR PREPARATION AND APPLICATIONS. | |
| CO6640335A2 (en) | Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity or prediabetes | |
| CL2008002247A1 (en) | Compounds derived from phenyl amide; Preparation process; pharmaceutical composition containing them; and its use in the preparation of drugs for the treatment of sleep disorders, narcolepsy and psychiatric disorders, among others. | |
| CR10062A (en) | COMPOSITIONS AND METHODS OF TREATMENT FOR DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
| EA200801081A1 (en) | METHODS OF TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM BY COMBINATION OF SMALL DOSES OF ESCITALOPRAM AND BUPROPION | |
| ATE459353T1 (en) | GABOXADOL USED TO TREAT DEPRESSION AND OTHER AFFECTIVE DISORDERS | |
| CL2012000097A1 (en) | Compounds derived from 3-phenoxymethylpyrrolidine, serotonin-norepinephrine reuptake inhibitors; preparation procedure; intermediate compounds; pharmaceutical composition comprising it; and its use in the treatment of pain disorders, depression, among others. | |
| NO20061167L (en) | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression | |
| PE20040924A1 (en) | ESCITALOPRAM BROMHYDRATE AND A METHOD FOR ITS PREPARATION | |
| AR045284A1 (en) | USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT | |
| DE60312874D1 (en) | COMBINATION THERAPY USING A SEROTONIN RECIPROCAL HEATER | |
| EA200801080A1 (en) | STABLE PHARMACEUTICAL MEDICINE FORMS CONTAINING ESCITALOPRAM AND BUPROPION | |
| MX2011012596A (en) | Methods of enhancing selective serotonin reuptake inhibitor effects in mammals. | |
| AR048134A1 (en) | THE COMBINATION OF AN INHIBITOR OF THE RECOVERY OF SEROTONINE AND AN ANTAGONIST OF THE RECEIVER OF HISTAMINE 3, THE INVESTED AGONIST OR THE PARTIAL AGONIST | |
| AR045314A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ANALEPTICS AND ANTIDEPRESSANTS | |
| DE60315843D1 (en) | ANTIDEPRESSIVE INDOLALKYL DERIVATIVES OF HETEROCYCLIC-CONDENSED BENZODIOXANETHYLAMINES | |
| BR0314431A (en) | Antidepressant piperidine derivatives of heterocyl-fused benzodioxanes | |
| ATE323094T1 (en) | ANTIDEPRESSANT CYCLOALKYLAMINE DERIVATIVES OF BENZODIOXANS CONDENSED WITH HETEROCYCLES | |
| CO5680440A2 (en) | COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED | |
| WO2005056056A3 (en) | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist | |
| ECSP066555A (en) | MORFOLINE DERIVATIVES AS INHIBITORS OF NOREPINEFRINE REABSORTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |